AKM Lab-01
Asset
Akkermansia muciniphila intervention intended to promote weight loss.
- Stage
- Human trials
- Modality
- Microbiome
- Target
- Not known
- 2
- Indications
- 2
- Trials
- 1
- Developer
Indications
2Hypercholesterolaemia
Human trials, Active not recruiting, NCT06974266, clinicaltrials.gov, 13 Oct 2026
Obesity overweight
Human trials, Recruiting, NCT07331974, clinicaltrials.gov, 13 Oct 2026
In the full profile
- Owner and partners1
- Trials2
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.